Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Jul-21 5:21 PM View:  | Crispr Therapeutics Ag (CRSP) | 19-Jul-21 | Market Sale (Planned) | 10,000 | $126.43 | $1,264,350.00 | (2%) 508.56K to 498.56K | 2% |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 29-Jun-21 | Market Sale (Planned) | 47,536 | $149.49 | $7,106,340.00 | (12%) 397.26K to 349.73K | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Acquisition (other) | 158,522 | -- | -- | 11% 1.39M to 1.54M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Acquisition (other) | 27,716 | -- | -- | 2% 1.54M to 1.57M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Acquisition (other) | 84,085 | -- | -- | 5% 1.57M to 1.66M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Acquisition (other) | 18,973 | -- | -- | 1% 1.66M to 1.68M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Acquisition (other) | 6,018 | -- | -- | < 1% 1.68M to 1.68M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Acquisition (other) | 847 | -- | -- | < 1% 1.68M to 1.68M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Disposition (other) | 248,625 | -- | -- | (15%) 1.68M to 1.43M | |
| 30-Jun-21 6:41 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Disposition (other) | 1,036,400 | -- | -- | (72%) 1.43M to 397.26K | |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 3,216 | $150.65 | $484,491.00 | (2%) 189.21K to 185.99K | < 1% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 1,578 | $150.65 | $237,726.00 | (< 1%) 185.99K to 184.41K | < 1% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 6,403 | $151.49 | $970,022.00 | (3%) 184.41K to 178.01K | < 1% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 3,144 | $151.49 | $476,300.00 | (2%) 178.01K to 174.87K | < 1% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 3,139 | $152.38 | $478,309.00 | (2%) 174.87K to 171.73K | 1% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 1,540 | $152.38 | $234,660.00 | (< 1%) 171.73K to 170.19K | 1% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 4,519 | $153.54 | $693,842.00 | (3%) 170.19K to 165.67K | 2% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 2,218 | $153.54 | $340,549.00 | (1%) 165.67K to 163.45K | 2% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 2,281 | $154.57 | $352,564.00 | (1%) 163.45K to 161.17K | 3% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 1,119 | $154.57 | $172,959.00 | (< 1%) 161.17K to 160.05K | 3% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 268 | $155.27 | $41,613.00 | (< 1%) 160.05K to 159.78K | 3% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 132 | $155.27 | $20,496.00 | (< 1%) 159.78K to 159.65K | 3% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 549 | $156.54 | $85,941.20 | (< 1%) 159.65K to 159.1K | 4% |
| 30-Jun-21 6:38 PM View: | Crispr Therapeutics Ag (CRSP) | 28-Jun-21 | Market Sale (Planned) | 269 | $156.54 | $42,109.60 | (< 1%) 159.1K to 158.83K | 4% |
| 30-Jun-21 5:05 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion | 8,455,910 | -- | -- | 2985% 283.25K to 8.74M | |
| 30-Jun-21 5:05 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 157,895 | $19.00 | $3,000,000.00 | 2% 8.74M to 8.9M | |
| 15-Jun-21 4:41 PM View: | Crispr Therapeutics Ag (CRSP) | 11-Jun-21 | Market Sale (Planned) | 10,000 | $126.61 | $1,266,120.00 | (< 1%) 1.59M to 1.58M | (2%) |
| 24-Mar-21 6:00 PM View: | Crispr Therapeutics Ag (CRSP) | 22-Mar-21 | Market Sale (Planned) | 30,374 | $132.37 | $4,020,670.00 | (2%) 1.62M to 1.59M | 4% |
| 03-Mar-21 4:23 PM View: | Crispr Therapeutics Ag (CRSP) | 01-Mar-21 | Acquisition (other) | 56,056 | -- | -- | 3% 1.88M to 1.94M | |
| 03-Mar-21 4:23 PM View: | Crispr Therapeutics Ag (CRSP) | 01-Mar-21 | Acquisition (other) | 12,648 | -- | -- | < 1% 1.94M to 1.95M | |
| 03-Mar-21 4:23 PM View: | Crispr Therapeutics Ag (CRSP) | 01-Mar-21 | Acquisition (other) | 4,012 | -- | -- | < 1% 1.95M to 1.95M | |
| 03-Mar-21 4:23 PM View: | Crispr Therapeutics Ag (CRSP) | 01-Mar-21 | Acquisition (other) | 565 | -- | -- | < 1% 1.95M to 1.95M | |
| 03-Mar-21 4:23 PM View: | Crispr Therapeutics Ag (CRSP) | 01-Mar-21 | Disposition (other) | 60,068 | -- | -- | (3%) 1.95M to 1.89M | |
| 03-Mar-21 4:23 PM View: | Crispr Therapeutics Ag (CRSP) | 01-Mar-21 | Disposition (other) | 278,097 | -- | -- | (15%) 1.89M to 1.62M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Acquisition (other) | 158,522 | -- | -- | 5% 3.04M to 3.2M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Acquisition (other) | 27,716 | -- | -- | < 1% 3.2M to 3.23M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Acquisition (other) | 84,085 | -- | -- | 3% 3.23M to 3.31M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Acquisition (other) | 18,973 | -- | -- | < 1% 3.31M to 3.33M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Acquisition (other) | 6,018 | -- | -- | < 1% 3.33M to 3.34M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Acquisition (other) | 847 | -- | -- | < 1% 3.34M to 3.34M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Disposition (other) | 1,285,030 | -- | -- | (39%) 3.34M to 2.05M | |
| 23-Feb-21 4:40 PM View: | Crispr Therapeutics Ag (CRSP) | 19-Feb-21 | Market Sale | 171,003 | $149.11 | $25,497,800.00 | (8%) 2.05M to 1.88M | |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 914 | $147.00 | $134,360.00 | (< 1%) 3.06M to 3.05M | (18%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 878 | $147.00 | $129,068.00 | (< 1%) 3.05M to 3.05M | (18%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 2,679 | $148.28 | $397,245.00 | (< 1%) 3.05M to 3.05M | (17%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 2,576 | $148.28 | $381,972.00 | (< 1%) 3.05M to 3.05M | (17%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 2,091 | $149.12 | $311,814.00 | (< 1%) 3.05M to 3.05M | (16%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 2,009 | $149.12 | $299,586.00 | (< 1%) 3.05M to 3.04M | (16%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 995 | $150.14 | $149,392.00 | (< 1%) 3.04M to 3.04M | (15%) |
| 18-Dec-20 7:12 PM View: | Crispr Therapeutics Ag (CRSP) | 16-Dec-20 | Market Sale (Planned) | 958 | $150.14 | $143,837.00 | (< 1%) 3.04M to 3.04M | (15%) |